Meghmani Organi.

Why is Meghmani Organics Ltd falling/rising?

As of 18-Jul, Meghmani Organics Ltd is seeing a slight short-term rise in stock price, currently at 46.93, but has underperformed significantly over the past year with a return of -52.52%. The stock's long-term fundamentals are weak, and declining investor participation indicates ongoing pressure.

As of 18-Jul, Meghmani Organics Ltd is experiencing a slight rise in its stock price, currently at 46.93, with a change of 0.08 (0.17%) upward. This increase can be attributed to a few factors. Notably, the stock has outperformed its sector by 0.38% today and has shown a consecutive gain over the last two days, accumulating a total return of 0.47% during this period.<BR><BR>However, despite this short-term rise, the stock has been underperforming in the longer term. Over the past year, it has generated a return of -52.52%, significantly lagging behind the benchmark Sensex, which has only declined by -4.99% in the same timeframe. Additionally, the stock is trading below its moving averages across various time frames, indicating a general downward trend.<BR><BR>Investor participation appears to be declining, as evidenced by a significant drop in delivery volume, which fell by 62.49% compared to the 5-day average. This suggests a lack of confidence among investors, which could counteract any short-term gains.<BR><BR>While the company has shown a remarkable profit increase of 371% over the past year, its long-term fundamentals are weak, with a -24.33% CAGR growth in operating profits over the last five years and a low return on equity of 7.13%. Furthermore, the stock is trading at a discount compared to its peers, but the lack of domestic mutual fund investment, which stands at 0%, indicates that institutional investors may not be comfortable with the current price or business outlook.<BR><BR>In summary, while Meghmani Organics Ltd is experiencing a minor rise in stock price in the short term, the broader context of its long-term performance and declining investor participation suggests that the stock remains under pressure overall.

Which are the latest news on Meghmani Organi.?

What does Meghmani Organi. do?

Meghmani Organics Ltd manufactures and sells pigment and agrochemical products, operating in the small-cap segment of the pesticides industry. As of March 2026, it reported net sales of ₹474 Cr and a net profit of ₹8 Cr, with a market cap of ₹1,213 Cr.

Overview:<BR>Meghmani Organics Ltd is engaged in the manufacturing and selling of pigment and agrochemical products, operating within the small-cap segment of the pesticides and agrochemicals industry.<BR><BR>History:<BR>The company was originally incorporated as 'Meghmani Organochem Limited' on 15 October 2019 and changed its name to "Meghmani Organics Limited" on 3rd August 2021. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 474 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 8 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 1,213 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 41.00<BR>- Industry P/E: 20<BR>- Dividend Yield: 0.00%<BR>- Debt-Equity: 0.45<BR>- Return on Equity: 1.86%<BR>- Price to Book: 0.79<BR><BR>Contact Details:<BR>Details: No Company Details Available<BR>Registrar Address: Not available.

How big is Meghmani Organi.?

As of 10th June, Meghmani Organics Ltd has a market capitalization of 1,213.00 Cr, with recent net sales of 2,173.96 Cr and a net profit of 28.73 Cr.

As of 10th June, Meghmani Organics Ltd has a market capitalization of 1,213.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Meghmani Organics reported Net Sales of 2,173.96 Cr and a Net Profit of 28.73 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 1,515.26 Cr and Total Assets of 3,085.41 Cr.

Who are in the management team of Meghmani Organi.?

The management team of Meghmani Organi includes key members such as Jayanti M Patel (Executive Chairman), Ashish N Soparkar and Natwarlal M Patel (Managing Directors), and several Executive and Independent Directors. This team is responsible for the company's strategic direction and management.

The management team of Meghmani Organi includes the following key members:<BR><BR>1. **Jayanti M Patel** - Executive Chairman<BR>2. **Ashish N Soparkar** - Managing Director<BR>3. **Natwarlal M Patel** - Managing Director<BR>4. **Ramesh M Patel** - Executive Director<BR>5. **Anand I Patel** - Executive Director<BR>6. **Urvashi Dhirubhai Shah** - Non-Executive & Independent Director<BR>7. **Manubhai Khodidas Patel** - Non-Executive & Independent Director<BR>8. **Ganapati D Yadav** - Non-Executive & Independent Director<BR>9. **Jayesh Patel** - Company Secretary & Compliance Officer<BR>10. **Varesh Sinha** - Independent Director<BR>11. **Nikunt Raval** - Additional Director<BR><BR>This team plays a crucial role in the strategic direction and management of the company.

Who are the peers of the Meghmani Organi.?

Peers of Meghmani Organics include Bharat Rasayan, Insecticid.India, India Pesticides, Astec Lifescienc, Punjab Chemicals, Dharmaj Crop, Heranba Inds, and Best Agrolife. Meghmani Organics has average management risk and a significantly lower 1-year return of -48.94% compared to its peers.

Peers: The peers of Meghmani Organi. are Bharat Rasayan, Insecticid.India, India Pesticides, Astec Lifescienc, Punjab Chemicals, Dharmaj Crop, Heranba Inds, and Best Agrolife.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bharat Rasayan, Insecticid.India, and India Pesticides, while Average management risk is found at Punjab Chemicals, Meghmani Organi., Dharmaj Crop, and Heranba Inds. Below Average management risk is noted for Astec Lifescienc. In terms of growth, Good growth is seen at Dharmaj Crop, while Below Average growth is present at Bharat Rasayan, Insecticid.India, India Pesticides, Punjab Chemicals, Meghmani Organi., Astec Lifescienc, Heranba Inds, and Best Agrolife. Capital Structure ratings show Excellent at Bharat Rasayan, Insecticid.India, and India Pesticides, Good at Punjab Chemicals, Average at Meghmani Organi., Heranba Inds, and Best Agrolife, and Below Average at Astec Lifescienc.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Dharmaj Crop at 0.44%, while the peer with the lowest is Meghmani Organi. at -48.94%, indicating that Meghmani Organi. has a significantly worse return compared to its peers. Additionally, peers such as Bharat Rasayan, India Pesticides, Punjab Chemicals, Heranba Inds, and Best Agrolife have negative six-month returns.

Are Meghmani Organics Ltd latest results good or bad?

Meghmani Organics Ltd's latest Q4 FY26 results are poor, with a 59.49% decline in net profit to ₹8.03 crores and a 14.30% drop in revenue to ₹474.34 crores, marking the lowest quarterly revenue in seven quarters and indicating significant operational challenges.

Meghmani Organics Ltd's latest results for Q4 FY26 indicate a challenging financial situation. The company reported a net profit of ₹8.03 crores, which represents a significant decline of 59.49% year-on-year. Revenue also fell sharply, down 14.30% to ₹474.34 crores, marking the lowest quarterly revenue in the past seven quarters. <BR><BR>Operating margins have deteriorated to just 4.16%, the weakest performance in over a year, down from 11.83% in the same quarter last year. This indicates severe pressure on pricing and cost structures, raising concerns about the company's ability to sustain profitability. Furthermore, the reliance on non-operating income is alarming, as it constituted over 520% of profit before tax, suggesting that core operations are struggling to generate sufficient income.<BR><BR>Overall, the financial performance reflects significant operational challenges, weak capital efficiency, and a concerning trend of declining revenues and profits. Given these factors, the results can be characterized as poor, highlighting the need for urgent operational improvements.

Should I buy, sell or hold Meghmani Organics Ltd?

When is the next results date for Meghmani Organics Ltd?

The next results date for Meghmani Organics Ltd is 14 May 2026.

The next results date for Meghmani Organics Ltd is scheduled for 14 May 2026.

Is Meghmani Organi. technically bullish or bearish?

As of November 14, 2025, Meghmani Organics has a bearish technical stance, indicated by bearish MACD, Bollinger Bands, moving averages, and KST across multiple timeframes, along with significant underperformance compared to the Sensex.

As of 14 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Meghmani Organics is bearish, with a moderate strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish Bollinger Bands on both weekly and monthly timeframes, and bearish moving averages on the daily timeframe. Additionally, the KST is bearish on both weekly and monthly timeframes, while the Dow Theory indicates a mildly bearish outlook on the weekly and monthly. The stock has underperformed significantly compared to the Sensex across multiple timeframes, further supporting the bearish sentiment.

How has been the historical performance of Meghmani Organi.?

Meghmani Organi's historical performance has been volatile, with net sales peaking at 2,552.62 Cr in March 2023 before declining to 2,079.75 Cr by March 2025, alongside a drop in operating profit and ongoing challenges reflected in negative profit after tax of -10.60 Cr in March 2025. Total liabilities increased to 3,085.41 Cr, indicating financial strain despite some recovery in profit before tax.

Answer:<BR>The historical performance of Meghmani Organi shows significant fluctuations in key financial metrics over the past five years.<BR><BR>Breakdown:<BR>Meghmani Organi's net sales peaked at 2,552.62 Cr in March 2023 but declined to 2,079.75 Cr by March 2025. The total operating income followed a similar trend, decreasing from 2,552.62 Cr in March 2023 to 2,079.75 Cr in March 2025. The company's operating profit (PBDIT) also saw a decline, reaching 186.62 Cr in March 2025 after a high of 474.75 Cr in March 2022. The profit before tax turned positive again in March 2025 at 9.47 Cr, recovering from a loss of 121.18 Cr in March 2024. However, the profit after tax remained negative at -10.60 Cr in March 2025, indicating ongoing challenges. The company's total liabilities increased from 2,797.61 Cr in March 2022 to 3,085.41 Cr in March 2025, while total assets also rose to 3,085.41 Cr in March 2025. Cash flow from operating activities decreased to 66.00 Cr in March 2025, down from 333.00 Cr in March 2021, reflecting a decline in operational efficiency. Overall, Meghmani Organi's financial performance has been volatile, with notable highs and lows across various metrics.

Is Meghmani Organi. overvalued or undervalued?

As of November 10, 2025, Meghmani Organics is considered undervalued with an attractive valuation grade, a PE ratio of 46.23, and strong growth potential, especially when compared to peers like Sudarshan Chemicals and Kiri Industries, despite its recent underperformance against the Sensex.

As of 10 November 2025, the valuation grade for Meghmani Organics has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued, particularly given its PE ratio of 46.23, an EV to EBITDA of 34.63, and a PEG ratio of 0.31, which suggests strong growth potential relative to its price. <BR><BR>In comparison to its peers, Meghmani stands out with a more favorable valuation than Sudarshan Chemicals, which is deemed expensive with a PE of 96.51, and Kiri Industries, which is classified as risky with a PE of 26.11. Additionally, while the stock has underperformed against the Sensex over various periods, including a 1-year decline of 29.12% compared to the Sensex's 5.09% gain, the attractive valuation suggests potential for recovery and growth in the future.

Who are the top shareholders of the Meghmani Organi.?

The top shareholders of Meghmani Organi include promoter Ashishbhai Natawarlal Soparkar with 10.59%, 45 Foreign Institutional Investors holding 1.81%, and public shareholder Gadia Naveen Vishwanath with 1.35%. Individual investors collectively own 37.9% of the shares.

The top shareholders of Meghmani Organi include the promoters, who hold the majority of the shares. The promoter with the highest holding is Ashishbhai Natawarlal Soparkar, who owns 10.59% of the company. Additionally, there are 45 Foreign Institutional Investors (FIIs) holding a combined 1.81% of the shares. The highest public shareholder is Gadia Naveen Vishwanath, with a holding of 1.35%. Individual investors collectively hold 37.9% of the shares.

Has Meghmani Organi. declared dividend?

Yes, Meghmani Organics Ltd has declared a 140% dividend, amounting to ₹1.4 per share, with an ex-date of June 20, 2023. However, the total returns over various periods have shown mixed performance, with a lack of dividend yield indicating minimal impact on overall returns.

Meghmani Organics Ltd has declared a 140% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 140%<BR>- Amount per share: 1.4<BR>- Ex-date: 20 Jun 23<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -4.3%, the dividend return was 0%, resulting in a total return of -4.3%.<BR><BR>Over the past year, the price return was 14.07%, the dividend return was 0%, leading to a total return of 14.07%.<BR><BR>For the 2-year period, the price return was 4.44%, the dividend return was 1.59%, resulting in a total return of 6.03%.<BR><BR>In the 3-year period, the price return was -30.83%, the dividend return was 1.26%, leading to a total return of -29.57%.<BR><BR>Over the last 4 years, the price return was 0%, the dividend return was 0%, resulting in a total return of 0.0%.<BR><BR>In the 5-year period, the price return was 0%, the dividend return was 0%, leading to a total return of 0.0%.<BR><BR>Overall, while Meghmani Organics Ltd has declared a significant dividend, the total returns over various periods show mixed performance, particularly with negative returns in the short and long term. The lack of dividend yield indicates that the dividend has not significantly impacted the overall returns.